- Home
- SID vs BCRX Comparison
SID vs BCRX Comparison
Compare SID & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SID
- BCRX
- Stock Information
- Founded
- SID 1941
- BCRX 1986
- Country
- SID Brazil
- BCRX United States
- Employees
- SID N/A
- BCRX N/A
- Industry
- SID Steel/Iron Ore
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SID Industrials
- BCRX Health Care
- Exchange
- SID Nasdaq
- BCRX Nasdaq
- Market Cap
- SID 1.9B
- BCRX 1.8B
- IPO Year
- SID 1997
- BCRX 1994
- Fundamental
- Price
- SID $1.52
- BCRX $7.91
- Analyst Decision
- SID Strong Sell
- BCRX Strong Buy
- Analyst Count
- SID 1
- BCRX 10
- Target Price
- SID $1.30
- BCRX $16.70
- AVG Volume (30 Days)
- SID 2.0M
- BCRX 2.2M
- Earning Date
- SID 11-11-2025
- BCRX 11-03-2025
- Dividend Yield
- SID 5.32%
- BCRX N/A
- EPS Growth
- SID N/A
- BCRX N/A
- EPS
- SID N/A
- BCRX N/A
- Revenue
- SID $8,202,474,486.00
- BCRX $557,506,000.00
- Revenue This Year
- SID $4.37
- BCRX $41.34
- Revenue Next Year
- SID $0.51
- BCRX $6.11
- P/E Ratio
- SID N/A
- BCRX N/A
- Revenue Growth
- SID 2.22
- BCRX 45.85
- 52 Week Low
- SID $1.24
- BCRX $6.02
- 52 Week High
- SID $2.50
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- SID 61.12
- BCRX 40.33
- Support Level
- SID $1.26
- BCRX $7.64
- Resistance Level
- SID $1.59
- BCRX $7.99
- Average True Range (ATR)
- SID 0.05
- BCRX 0.21
- MACD
- SID 0.01
- BCRX -0.03
- Stochastic Oscillator
- SID 65.22
- BCRX 31.18
About SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.